Evaluation of expression of polymorphonuclear neutrophil surface receptors in patients with type 1 diabetes;Ocena ekspresji receptorów powierzchniowych granulocytów obojȩtnochłonnych u chorych na cukrzycȩ typu 1

Polskie Archiwum Medycyny Wewnetrznej

Volumn 105, Issue 5, 2001, Pages 377-381

  Grykiel, Krzysztof ^a   Zozulińska, Dorota ^a   Kostrzewa, Artur ^b   Wiktorowicz, Krzysztof ^b   Wierusz Wysocka, Bogna ^a  

^a Szpital im F Raszei w Poznaniu   (Poland)

^b Pracownia Immunologii Komorkowej A ^*

Author keywords

Diabetes mellitus; Inflammatory process; Polymorphonuclear neutrophils; Surface receptors

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE ACTIVATION; MALE; METABOLISM; MIDDLE AGED; NEUTROPHIL;

ADULT; ANTIGENS, CD18; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; FLOW CYTOMETRY; HUMANS; MACROPHAGE-1 ANTIGEN; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS;

EID: 0035352743     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Carlos T.M., Harlan JM.: Leukocyte-Endothelial Adhesion Molecules. Blood, 1994, 84, 2068.
2. Weiss S.J.: Tissue destruction by neutrophils. N. Engl. J. Med., 1989, 320 365-376.
3. Arnould T., Michiels C., Remade J.: Increased PMN adherence on endothelial cells after hipoxia: involvement of PAF, CD18/CD11b and ICAM-1. Am. J. Physiol., 1993, 264C, 1102.
4. Bayones J.W.: Role of oxidative stress in development of complications in diabetes. Diabetes 1992, 40, 405.
5. Marhoffer W., Stein M., Maeser E., Federlin K.: Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 1992, 15, 256.
6. Radoff S., Vlassara H., Ceramu A.: Isolation of macrophage receptor for proteins modified by advenced glycosylation end products AGE. Fed. Proc., 1987, 46, 216.
7. Abbs A.K., Lichtman A.H., Pober J.S.: Cytokines. In: Cellular and Molecular Immunology. Ed. Abbas A.K., Lichtman A.H., Pober J.S., Sanders W.B., Eds. Philadelphia, London, Toronto, Montreal, Sydney, Tokyo, Harcourt Brace Jovanovich Inc., 1991, p. 225.
8. Patarroyo M., Makgoba M.W.: Leukocyte adhesion to cells in immune and inflammatory responses. Lancet, 1989, 11, 1139.
9. Wautier J.L., Setiadi H., Vilette D., Weill D., Wautier M.P.: Leukocyte adhesion to endothelial cells. Biorheology, 1990, 27, 3-4, 425.
10. Barouch F.C., Miyamoto K., Allport I.R. i wsp.: Integrin, mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest. Opthalmol. Vis. Sci., 2000, 41(5): 1153.
11. Rao K.M., Hatchell D.L., Cohen H.J.: Alterations in stimulus-induced integrin expression in peripheral blond neutrophils of patients with diabetic retinopathy. Am. J. MED. Sci., 1997 , 313 (3), 131.
12. Nguyen P., Broussas M., Hezard N.: Modulators of leukocytic functions. J. Mal. Vasc., 1998, 23 (2), 119.
13. Inoue T., Sakai Y., Fujito T. i wsp.: Expression of platelet membrane proteins after coronary angioplasty: a role in acute occlusion or long term restenosis. Circulation 1995, 92 (suppl. I), I-92.
14. Mickelson J.K., Lakkis N.M., Villarreal-Levy G. i wsp.: Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? J. Am. Col. Cardiol., 1996, 28, 345.
15. Wierusz-Wysocka B., Wysocki H., Wykrȩtowicz A. i wsp.: The influence of increasing glucose concentrations on selected functions of polymorphonuclear neutrophils. Acta Diabetol. Lat., 1988, 25, 283.
16. Roitt L, Brostoff J., Male D.: Immunologia. Wyd. J. Zeromski, Wyd. Med., Slowinski Verlag, Brema, 1996, 8.8-8.13, 14.1.
17. Tatoń J., Czech A.: Insulina - fizjologia, farmakologia, insulinoterapia cukrzycy. Wydawnictwo Naukowe PWN, Warszawa, 1995.
18. Shaw K.M.: Powikłania cukrzycy. Via Medica, Gdańsk, 1998.
19. Wierusz-Wysocka B., Zozulińska D.: Rola molekuł adhezyjnych w patogenezie cukrzycy typu 1 oraz późnych powikłań schorzenia. Med. Metabol., 1998, 2, 41, 45.
20. Ceriello A., Bortolotti N., Motz A. i wsp.: Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care, 1998, 21, 1529.